Optimizing clinical trials

Israel’s PhaseV develops causal machine learning (ML) technology that optimizes clinical trial design and analysis. Its goal is to prevent bio-techs wasting money on failed or badly designed trials of new treatments.  It boosts clinical trial success rates while maximizing resource and time efficiency.



This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *